• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share
FOR IMMEDIATE RELEASE
June 14, 2018
Contact: HHS Press Office
202-690-6343
media@hhs.gov

HHS Secretary Azar Praises FDA Approval of Generic Drugs for Treating Opioid Dependence

HHS Secretary Alex Azar issued the following statement regarding the Food and Drug Administration’s approval of generic versions of Suboxone, a medication used to treat opioid dependence:

“Medication-assisted treatment is a vital element of the Trump Administration’s work to combat the opioid crisis. We know it is effective, and we know more Americans need access to it. That is why we are so pleased that the FDA has approved generic versions of one medication-assisted treatment option. These approvals will help increase competition, lower cost, and save lives, advancing HHS’s priorities to lower drug prices and combat the opioid epidemic. The efficient and effective work being done by the FDA in approving addiction treatment options is an important part of HHS’s five-point strategy for the opioid crisis and reflects President Trump’s commitment to helping Americans struggling with addiction.”

Read more about FDA’s actions here: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm610807.htm

Read Secretary Azar’s remarks to the National Governors Association about the importance of medication-assisted treatment here:

https://www.hhs.gov/about/leadership/secretary/speeches/2018-speeches/plenary-addres-to-national-governors-association.html

###
Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook Exit disclaimer icon, follow HHS on Twitter @HHSgov Exit disclaimer icon, and sign up for HHS Email Updates.
Last revised: June 14, 2018

Subscribe to RSS

Receive latest updates

Subscribe to our RSS